nasal delivery
![Neffy FDA rejection, ARS Pharmaceuticals nasal spray epinephrine, Neffy vs EpiPen, Neffy appeal and resubmission, Neffy anaphylaxis treatment, ARS Pharmaceuticals stock price SPRY, Neffy repeat-dose study,](https://pharmtales.com/wp-content/uploads/2023/09/FDA-denies-approval-for-Neffy-ARS-Pharmaceuticals-needle-free-EpiPen-alternative-citing-safety-concerns.jpg)
FDA denies approval for Neffy, ARS Pharmaceuticalsâ needle-free EpiPen alternative, citing safety concerns
Anika Sharma
While positive votes from FDA advisory committees often bode well for drug approvals, ARS Pharmaceuticals experienced an unexpected setback when ...